35:16

ALS Update October 2025: Signs of Progress, Reasons for Hope | Dr. Richard Bedlack

1:30:15

Signals from the Outer Limits - What I've Learned from Slow Progressors and ALS Reversals

1:17:41

Updates on ALS Clinical Trials from Regeneron and VectorY

1:06:47

A Conversation with an MPN Specialist: Blood Count Targets in PV

58:24

An Introduction to New Clinical Guidance for Those At Risk for Genetic ALS and FTD